| 1.1 Disease activity at study end |
2 |
479 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.03 [‐0.25, 0.20] |
| 1.1.1 IBD (3 months post intervention) |
1 |
179 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.26 [‐0.56, 0.03] |
| 1.1.2 CD (TELE‐IBD every other week) |
1 |
104 |
Std. Mean Difference (IV, Random, 95% CI) |
0.13 [‐0.27, 0.54] |
| 1.1.3 CD (TELE‐IBD weekly) |
1 |
99 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.14 [‐0.55, 0.27] |
| 1.1.4 UC (TELE‐IBD every other week) |
1 |
48 |
Std. Mean Difference (IV, Random, 95% CI) |
0.17 [‐0.42, 0.76] |
| 1.1.5 UC (TELE‐IBD weekly) |
1 |
49 |
Std. Mean Difference (IV, Random, 95% CI) |
0.35 [‐0.23, 0.94] |
| 1.2 Disease activity at study end (fixed‐effect sensitivity analysis) |
2 |
479 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.05 [‐0.24, 0.13] |
| 1.2.1 IBD (3 months post intervention) |
1 |
179 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.26 [‐0.56, 0.03] |
| 1.2.2 CD (TELE‐IBD every other week) |
1 |
104 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.13 [‐0.27, 0.54] |
| 1.2.3 CD (TELE‐IBD weekly) |
1 |
99 |
Std. Mean Difference (IV, Fixed, 95% CI) |
‐0.14 [‐0.55, 0.27] |
| 1.2.4 UC (TELE‐IBD every other week) |
1 |
48 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.17 [‐0.42, 0.76] |
| 1.2.5 UC (TELE‐IBD weekly) |
1 |
49 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.35 [‐0.23, 0.94] |
| 1.3 Flare‐ups or relapse (continuous) |
2 |
1022 |
Mean Difference (IV, Random, 95% CI) |
‐0.00 [‐0.06, 0.05] |
| 1.4 Flare‐ups or relapse (continuous ‐ fixed‐effect sensitivity analysis) |
2 |
1022 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.00 [‐0.06, 0.05] |
| 1.5 Flare‐ups or relapse (dichotomous) |
3 |
307 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.41, 2.18] |
| 1.6 Flare‐ups or relapse (dichotomous: fixed‐effect sensitivity analysis) |
3 |
307 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.96 [0.42, 2.20] |
| 1.7 Quality of life at study end |
6 |
1364 |
Std. Mean Difference (IV, Random, 95% CI) |
0.08 [‐0.03, 0.18] |
| 1.8 Quality of life at study end (fixed‐effect sensitivity analysis) |
6 |
1364 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.08 [‐0.03, 0.18] |
| 1.9 Quality of life at study end: sensitivity analysis for risk of bias |
1 |
300 |
Mean Difference (IV, Random, 95% CI) |
1.11 [‐5.74, 7.97] |
| 1.10 Quality of life at study end: sensitivity analysis excluding cluster‐RCTs |
5 |
1238 |
Std. Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.04, 0.18] |
| 1.11 Quality of life at study end: sensitivity analysis using IBDQ only |
4 |
514 |
Mean Difference (IV, Random, 95% CI) |
1.82 [‐3.72, 7.36] |
